Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 18/20 | 1.00 |
| ▸ | HDAC3 | O15379 | 8/20 | 1.00 |
| ▸ | HDAC2 | Q92769 | 8/20 | 1.00 |
| ▸ | NAMPT | P43490 | 5/20 | 1.00 |
| ▸ | NCOR2 | Q9Y618 | 4/20 | 1.00 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 1.00 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 1.00 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 1.00 |
| ▸ | HDAC4 | P56524 | 3/20 | 1.00 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 1.00 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 1.00 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 1.00 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 1.00 |
| ▸ | NCOR1 | O75376 | 1/20 | 0.86 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tucidinostat SCHEMBL29813059 | 1.00 | HDAC1 (1.00) | HDAC1HDAC3HDAC2NAMPTNCOR2 | |
| Tucidinostat SCHEMBL29350211 | 1.00 | HDAC1 (1.00) | HDAC1HDAC3HDAC2NAMPTNCOR2 | |
| Tucidinostat SCHEMBL13815849 | 1.00 | HDAC1 (1.00) | HDAC1HDAC3HDAC2NAMPTNCOR2 | |
| SCHEMBL8057949 | 0.93 | HDAC1 (1.00) | HDAC1HDAC3HDAC2NAMPTNCOR2 | |
| SCHEMBL5500152 | 0.93 | HDAC1 (1.00) | HDAC1HDAC3HDAC2NAMPTNCOR2 | |
| SCHEMBL30267913 | 0.93 | HDAC1 (1.00) | HDAC1HDAC3HDAC2NAMPTNCOR2 | |
| Tucidinostat SCHEMBL31697749 | 0.92 | HDAC1 (0.85) | HDAC1HDAC3HDAC2NAMPTNCOR2 | |
| Tucidinostat SCHEMBL30497063 | 0.91 | HDAC1 (0.84) | HDAC1HDAC3HDAC2NAMPTNCOR2 | |
| SCHEMBL24372333 | 0.89 | HDAC1 (0.80) | HDAC1HDAC3HDAC2NAMPTNCOR2 | |
| SCHEMBL4476526 | 0.89 | HDAC1 (1.00) | HDAC1HDAC3HDAC2NAMPTNCOR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11377423-B2 | Inhibitors of histone deacetylase | THE BROAD INSTITUTE, INC. (US) | 2022-07-05 | — | — | US | disclosed |
| EP-2930169-B1 | CRYSTAL FORM OF CHIDAMIDE, PREPARATION METHOD AND USE THEREOF | SHENZHEN CHIPSCREEN BIOSCIENCES LTD (CN) | 2018-07-18 | — | — | EP | disclosed |
| US-20180072671-A1 | INHIBITORS OF HISTONE DEACETYLASE | THE BROAD INSTITUTE, INC. (US) | 2018-03-15 | — | — | US | disclosed |
| US-9790184-B2 | Inhibitors of histone deacetylase | THE BROAD INSTITUTE, INC. (US) | 2017-10-17 | — | — | US | disclosed |
| US-9573901-B2 | Crystal form of chidamide, preparation method and use thereof | SHENZHEN CHIPSCREEN BIOSCIENCES, LTD. (CN) | 2017-02-21 | — | — | US | disclosed |
| US-20150299126-A1 | CRYSTAL FORM OF CHIDAMIDE, PREPARATION METHOD AND USE THEREOF | SHENZHEN CHIPSCREEN BIOSCIENCES, LTD. (CN) | 2015-10-22 | — | — | US | disclosed |
| EP-2930169-A1 | CRYSTAL FORM OF CHIDAMIDE, PREPARATION METHOD AND USE THEREOF | Shenzhen Chipscreen Biosciences, Ltd. (CN) | 2015-10-14 | — | — | EP | disclosed |
| US-20150191427-A1 | INHIBITORS OF HISTONE DEACETYLASE | THE GENERAL HOSPITAL CORPORATION D/B/A MASSACHUSETTS GENERAL HOSPITAL (US) | 2015-07-09 | — | — | US | disclosed |
| EP-2877444-A1 | INHIBITORS OF HISTONE DEACETYLASE | The Broad Institute, Inc. (US) | 2015-06-03 | — | — | EP | disclosed |
| WO-2014018979-A1 | INHIBITORS OF HISTONE DEACETYLASE | THE BROAD INSTITUTE, INC. (US) | 2014-01-30 | — | — | WO | disclosed |
| US-7550490-B2 | Benzamide derivatives as histone deacetylase inhibitors with potent differentiation and anti-proliferation activity | SHENZHEN CHIPSCREEN BIOSCIENCES LTD. (CN) | 2009-06-23 | — | — | US | disclosed |
| US-20080039509-A1 | Histone Deacetylase Inhibitors or Novel Benzamine Derivatives with Potent Differentiation and Anti-Proliferation Activity | SHENZHEN CHIPSCREEN BIOSCIENCES, LTD. | 2008-02-14 | — | — | US | disclosed |
| US-7244751-B2 | Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity | SHENZHEN CHIPSCREEN BIOSCIENCES LTD. (CN) | 2007-07-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150299126-A1 | CRYSTAL FORM OF CHIDAMIDE, PREPARATION METHOD AND USE THEREOF | CHIA, CRYAB, CYP21A2 | HDAC1 49/4885HDAC3 45/4885HDAC2 122/4885 |
| US-20180072671-A1 | INHIBITORS OF HISTONE DEACETYLASE | HDAC3, HDAC1, HDAC11 | HDAC1 2/4885HDAC3 1/4885HDAC2 5/4885 |
| US-20080039509-A1 | Histone Deacetylase Inhibitors or Novel Benzamine Derivatives with Potent Differentiation and Anti-Proliferation Activity | HDAC5, HDAC1, HDAC7 | HDAC1 2/4885HDAC3 12/4885HDAC2 8/4885 |
| US-20150191427-A1 | INHIBITORS OF HISTONE DEACETYLASE | HDAC3, HDAC1, HDAC5 | HDAC1 2/4885HDAC3 1/4885HDAC2 5/4885 |
| US-11377423-B2 | Inhibitors of histone deacetylase | HDAC3, HDAC1, HDAC11 | HDAC1 2/4885HDAC3 1/4885HDAC2 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.